39.68
Guardian Pharmacy Services Inc Azioni (GRDN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
4.51%
351.77
|
336.60 | 397.62 | 377.43 | 344.33 |
| Cost Of Revenue |
4.39%
271.72
|
260.29 | 312.11 | 302.71 | 276.19 |
| Gross Profit |
4.89%
80.04
|
76.31 | 85.50 | 74.72 | 68.15 |
| Selling, General, and Administrative |
1.31%
59.40
|
58.63 | 54.74 | - | - |
| Operating Income/Loss |
16.80%
20.64
|
17.68 | 30.76 | 16.35 | 12.58 |
| Nonoperating Income/Loss |
1,380%
9.148
|
0.618 | 0.337 | 0.277 | 0.007 |
| Income/Loss From Continuing Operations Before Tax |
62.86%
29.79
|
18.29 | 31.10 | 16.63 | 12.59 |
| Income Tax Expense/Benefit |
61.53%
7.671
|
4.749 | 9.834 | 7.038 | 3.76 |
| Income/Loss From Continuing Operations After Tax |
63.33%
22.12
|
13.54 | 21.27 | 9.593 | 8.827 |
| Net Income/Loss |
63.33%
22.12
|
13.54 | 21.27 | 9.593 | 8.827 |
| Attributable To Noncontrolling Interest |
0.00%
0.249
|
0.249 | 0.342 | -0.225 | -0.203 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):